Treatment-centred prevention: An integrated biomedical and social approach to HIV prevention

AIDS

Volumn 25, Issue 11, 2011, Pages 1435-1437

  Delva, Wim ^a,b,f   Verguet, Stéphane ^c   Hargrove, John ^a   Williams, Brian ^a   Sheneberger, Robert ^d   Stander, Tienie ^e   Welte, Alex ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Health Econometrix and Outcomes Research   (South Africa)

^f NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COST BENEFIT ANALYSIS; EMPOWERMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; JOB ACCOMMODATION; LETTER; MALE HOMOSEXUAL; MORBIDITY; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 79959927235     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283488503     Document Type: Letter

References (18)

1. Nguyen VK, Bajos N, Dubois-Arber F, O'Malley J, Pirkle CM. Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention. AIDS 2011; 25:291-293.
2. Del Romero J, Castilla J, Hernando V, Rodriguez C, Garcia S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ 2010; 340:c2205.
3. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
4. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376:532-539.
5. Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 2011; 25:473-477.
6. Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chene G, et al. Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy: the CASCADE collaboration-a collaboration of 23 cohort studies. PLoS Med 2010; 7:e1000239.
7. Welte A, Hargrove J, Delva W, Williams B, Stander T. How different are the costs and consequences of delayed versus immediate HIV treatment? S Afr Med J 2011; 101: 377-380.
8. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20:85-92. (Pubitemid 41818118)
9. Venkatesh KK, de Bruyn G, Lurie MN, Mohapi L, Pronyk P, Moshabela M, et al. Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS 2010; 24: 2687-2696.
10. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-693.
11. Carter MW, Kraft JM, Koppenhaver T, Galavotti C, Roels TH, Kilmarx PH, et al. 'A bull cannot be contained in a single kraal': concurrent sexual partnerships in Botswana. AIDS Behav 2007; 11:822-830. (Pubitemid 47599010)
12. Mah TL, Halperin DT. Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS Behav 2008; 14:11-16.
13. Sandøy IF, Dzekedzeke K, Fylkesnes K. Prevalence and correlates of concurrent sexual partnerships in Zambia. AIDS Behav 2010; 14:59-71.
14. Helleringer S, Kohler HP, Kalilani-Phiri L, Mkandawire J, Armbruster B. The reliability of sexual partnership histories: implications for the measurement of partnership concurrency during surveys. AIDS 2011; 25:503-511.
15. Abu-Raddad LJ, Longini IM Jr. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008; 22:1055-1061. (Pubitemid 351769744)
16. Kippax S. Understanding and integrating the structural and biomedical determinants of HIV infection: a way forward for prevention. Curr Opin HIV AIDS 2008; 3:489-494.
17. Merson M, Padian N, Coates TJ, Gupta GR, Bertozzi SM, Piot P, et al. Combination HIV prevention. Lancet 2008; 372:1805-1806.
18. Wand H, Ramjee G. Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning. AIDS Behav 2011; 15:479-486.